***TASK***
the task is to simplify the input abstract of a biomedical literature

***INPUT***
the input is the abstract of a biomedical literature

***OUTPUT***
the output is the simplified abstract for the input abstract of a biomedical literature

***DOCUMENTATION***

***EXAMPLES***

Input: We included four trials in this review and did not identify new studies from the search in April 2015. Home-based end-of-life care increased the likelihood of dying at home compared with usual care (risk ratio (RR) 1.33, 95% confidence interval (CI) 1.14 to 1.55, P = 0.0002; Chi2 = 1.72, df = 2, P = 0.42, I2 = 0%; 3 trials; N = 652; high quality evidence). Admission to hospital while receiving home-based end-of-life care varied between trials, and this was reflected by a high level of statistical heterogeneity in this analysis (range RR 0.62 to RR 2.61; 4 trials; N = 823; moderate quality evidence). Home-based end-of-life care may slightly improve patient satisfaction at one-month follow-up and reduce it at six-month follow-up (2 trials; low quality evidence). The effect on caregivers is uncertain (2 trials; low quality evidence). The intervention may slightly reduce healthcare costs (2 trials, low quality evidence). No trial reported costs to patients and caregivers. The evidence included in this review supports the use of home-based end-of-life care programmes for increasing the number of people who will die at home, although the numbers of people admitted to hospital while receiving end-of-life care should be monitored. Future research should systematically assess the impact of home-based end-of-life care on caregivers.
Output:

We searched the literature until April 2015 and found no new trials for this update. We found four trials for the previous updates. We included four trials in our review and report that people receiving end-of-life care at home are more likely to die at home. It is unclear whether home-based end-of-life care increases or decreases the probability of being admitted to hospital. Admission to hospital while receiving home-based end-of-life care varied between trials. People who receive end-of-life care at home may be slightly more satisfied after one month and less satisfied after six months. It is unclear whether home-based end-of-life care reduces or increases caregiver burden. Healthcare costs are uncertain, and no data on costs to participants and their families were reported. People who receive end-of-life care at home are more likely to die at home. There were few data on the impact of home-based end-of-life services on family members and lay caregivers.